1 enrolling by invitation. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Enrolling by invitation 1 |
Follow MASLD: new trials by email Literature Review of MASLD trials Research Report on MASLD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study) early time restricted Mediterranean diet, Mysimba - Diabetes Mellitus, Type 2, Liver Fibrosis | Phase 4 | Enrolling by invitation | Carmen Dietvorst | 70 | 2025-04-14 | 2026-04-21 |
Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Dyslipidemias (1) · Fatty Liver (1) · Hypertension (1) · Intermittent Fasting (1) · Liver Cirrhosis (1) · Liver Diseases (1) · Obesity (1) · Overweight (1)
Behavior (1) · Body Weight (1) · Cardiovascular Diseases (1) · Digestive System Diseases (1) · Endocrine System Diseases (1) · Fasting (1) · Feeding Behavior (1) · Fibrosis (1) · Glucose Metabolism Disorders (1) · Lipid Metabolism Disorders (1) · Metabolic Diseases (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Overnutrition (1) · Pathologic Processes (1)
Bupropion (1) · Diet Therapy (1) · Diet, Mediterranean (1) · Naltrexone (1) · bupropion hydrochloride, naltrexone hydrochoride drug combination (1)
Carmen Dietvorst (1)
Netherlands (1)
Manuel Castro Cabezas, Dr. (1)